Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06612268 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | Clinical Trial |
| Target Enrollment | 408 participants |
| Active Locations | 50 sites in the US |
| Sponsor | Novo Nordisk A/S |
| Last Updated on CT.gov | February 11, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06612268 is currently recruiting participants. This clinical trial study for sickle cell disease is actively seeking new participants at 50 locations across the United States. The study is sponsored by Novo Nordisk A/S. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06612268 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06612268 was last updated 2 weeks ago (February 11, 2026). HelloStudys verifies this status automatically.